Altoida, Inc. Email Format
Hospitals and Health CareDistrict of Columbia, United States11-50 Employees
Altoida, Inc. operates in the Hospitals and Health Care sector and is based in Washington, District of Columbia. It is a privately held company that develops digital biomarkers for neurological conditions, including Alzheimer's Disease, using augmented reality and machine learning. Its platform aims to provide objective evaluation of an individual's cognitive health and function, potentially enabling faster and more sensitive monitoring of disease progression and treatment response. The company's approach builds on more than 20 years of scientific research, with findings published in peer-reviewed journals including Nature Digital Medicine. In December 2023, Altoida announced results from the RADAR-AD consortium study, illustrating its involvement in collaborative research on digital biomarkers for neurodegenerative diseases.